PKAN Online-Treffen am 25.09.2024 – jetzt anmelden!

Liebe Familien, der Austausch unter Betroffenen bzw. deren Familien kann unglaublich wertvoll...

Aus einer Geschenkspende werden zwei

Seit einiger Zeit gibt es auf unserer Website die Möglichkeit, mit dem Spendenformular eine...

NBIA-Gentherapie Updates

Historische Spende von 1,2 Millionen Dollar gibt Treibstoff für PKAN-Gentherapie Eine...

Dr. Ivano Di Meo erhält $100.000 Förderung für die INAD-Forschung

Die NBIA Disorders Association freut sich, die Ergebnisse der Ausschreibung für ein Stipendium in...

Globale Zusammenarbeit führt zu Fortschritten in der MPAN-Forschung

Im November 2022 vergab Hoffnungsbaum e.V. zusammen mit den Schwesterorganisationen NBIA Disorders...

CoA Therapeutics bricht Klinische Studie für PKAN ab

Schweren Herzens teilen wir der Gemeinschaft mit, dass CoA Therapeutics beschlossen hat, die...

Zwei BPAN-Forschungsprojekte durch den MDBR 2023 mit je $60.000 gefördert

Der 10. jährliche Million Dollar Bike Ride (MDBR), der vom Orphan Disease Center der University of...

Vorantreiben der PKAN-Gentherapie: eine gemeinschaftliche Initiative

Die Erforschung einer Gentherapie für Pantothenat-Kinase-assoziierten Neurodegeneration (PKAN)...

NBIAcure bereitet Antrag auf FDA-Zulassung für CoA-Z vor

NBIAcure, ein Forschungsteam unter der Leitung von Dr. Susan Hayflick und Dr. Penny Hogarth, das...

Update on the CoA-Z clinical trial

Over the past few months, the OHSU CoA-Z study team has shared the initial study results with all...

Hoffnungsbaum e.V.

Here we give you an insight into the current association work of Hoffnungsbaum e.V..

8th International Symposium on NBIA in Switzerland

8th International Symposium on NBIA in Switzerland

NBIA scientists will meet to share their research from October 13-15 in Lausanne, Switzerland, at the 8th International NBIA Symposium. More than 20 scientists and physicians from all over the world will present the results of their NBIA projects in...

read more

NBIA Family Conference 2022 postponed!

Hoffnungsbaum e.V. wanted to host the 9th NBIA Family Conference in Germany in September 2022 at the Heilbronn Youth Hostel. We were very much looking forward to finally being able to get an in-person meeting of NBIA families again after two years of pandemic.

read more
Generational change in the Management Board of Hoffnungsbaum

Generational change in the Management Board of Hoffnungsbaum

On 21.11.2021, the annual general meeting of Hoffnungsbaum e.V. (HoBa) took place - with groundbreaking decisions for the future of our NBIA patient organization through the completion of the generational change in the association's management and the reorganization...

read more
Review of TIRCON and its significance for NBIA research and care

Review of TIRCON and its significance for NBIA research and care

A retrospective article on TIRCON (Treat Iron-Related Childhood-Onset Neurodegeneration) has now been published in the journal "Frontiers in Neurology" on the subject of "Networks for movement disorders". From 2011 to 2015, TIRCON is a project funded by the European Union...

read more
Hoffnungsbaum Newsletter 2020

Hoffnungsbaum Newsletter 2020

We have once again put together a newsletter for you in 2020. It contains information on the association's activities in 2020 and an outlook for next year. If you would like to be kept up to date, please subscribe to our online newsletter.

read more

Results of the Hoffnungsbaum survey 2020

In the period August - September 2020 Hoffnungsbaum e.V. conducted a broad-based opinion survey among all association members and NBIA families in Germany, Austria and Switzerland with whom we are in contact. The aim of the survey was to explore...

read more

Subscribe to our Hoffnungsbaum newsletter!

With our newsletter e-mails you will receive valuable information about NBIA. If you would like to receive additional information on individual NBIA variants or special information for researchers/clinicians in addition to the general newsletter, please click here: Subscribe to additional information

Privacy policy

You have successfully registered!